Patent · US Active

Salt hydrates

US8058301B2 · kind B2 · utility

0Cited by

3References

2Claims

0Family size

Assignee

Novartis AG · CH

Inventor

Erwin Marti · Basel, CH

Key dates

Filing date	Dec 15, 2004
Grant date	Nov 15, 2011
Priority date	—
Expiry date	Apr 17, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to new forms of salts of valsartan or crystalline, also partly crystalline and amorphous salts of valsartan, the respective production and usage, and pharmaceutical preparations containing such a salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.